Theo C. Manschreck

Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

Richard S.E. Keefe, Robert M. Bilder, Philip D. Harvey et al. · Neuropsychopharmacology · 2006 · 467 citations · Full text

Catie Schizophrenia Trial, Neuropsychological Functioning, Neuropsychology +10

Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12‐q13.1: Part 1

Ann E. Pulver, Maria Karayiorgou, Paula Wolyniec et al. · American Journal of Medical Genetics · 1994 · 382 citations · Full text

Semantic priming in thought disordered schizophrenic patients

Theo C. Manschreck, Brendan A. Maher, James J. Milavetz et al. · Schizophrenia Research · 1988 · 261 citations

Cognitive Science, Psychiatry, Semantic Priming +9

A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

Donald Goff, J. Steven Lamberti, Andrew C. Leon et al. · Neuropsychopharmacology · 2007 · 179 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +12

Disturbed voluntary motor activity in schizophrenic disorder

Theo C. Manschreck, Brendan A. Maher, Mary E. Rucklos et al. · Psychological Medicine · 1982 · 167 citations

Neuropsychology, Motor Features, Neuropsychiatry +20